RCUS Arcus Biosciences, Inc.
NYSE · SEC CIK 1724521 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $14.41M 24 sales by 7 insiders
- Filings on record
- 172 since 2021-08-05, latest 2026-08-24 17:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Jaen Juan C. | Pres | — | $9.22M |
| Jarrett Jennifer | COO | — | $2.17M |
| ROSEN TERRY J | CEO, Dir | — | $1.20M |
| Goeltz II Robert C. | CFO | — | $855.9K |
| Azoy Alexander | CAO | — | $432.5K |
| Tang Carolyn C. | GC | — | $318.5K |
| Markus Richard | Chief Medical Off | — | $210.1K |
| Ribas Antoni | Dir | — | — |
| Lambert Nicole | Dir | — | — |
| Lacey David L. | Dir | — | — |
Transactions 177
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-24 17:52 | 2026-08-21 | RCUS | Azoy Alexander | CAO | M - OptEx | $15.44 | +2,827 | 42.4K | +7% | +$43.6K |
| DT | 2026-08-24 17:52 | 2026-08-21 | RCUS | Azoy Alexander | CAO | S - Sale+OE | $30.00 | -2,827 | 39.6K | -7% | -$84.8K |
| MTI | 2026-07-13 17:36 | 2026-07-09+ | RCUS | Jaen Juan C. | Pres | S - Sale | $29.63 | -68.6K | 822.2K | -8% | -$2.03M |
| MTI | 2026-06-24 17:41 | 2026-06-22+ | RCUS | Jaen Juan C. | Pres | S - Sale | $27.92 | -31.4K | 890.8K | -3% | -$877.5K |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +5,700 | 43.0K | +15% | $0 |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Machado Patrick | Dir | A - Grant | $0.00 | +5,700 | 44.3K | +15% | $0 |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | KANEKO YASUNORI | Dir | A - Grant | $0.00 | +5,700 | 25.7K | +28% | $0 |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Tang Carolyn C. | GC | M - OptEx | $2.57 | +34.1K | 184.6K | +23% | +$87.7K |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Lacey David L. | Dir | A - Grant | $0.00 | +5,700 | 76.7K | +8% | $0 |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +5,700 | 44.3K | +15% | $0 |
| D | 2026-06-12 16:27 | 2026-06-11 | RCUS | Ribas Antoni | Dir | A - Grant | $0.00 | +5,700 | 44.3K | +15% | $0 |
| D | 2026-06-12 16:27 | 2026-06-11 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +5,700 | 48.3K | +13% | $0 |
| T | 2026-06-01 19:23 | 2026-06-01 | RCUS | Azoy Alexander | CAO | S - Sale | $25.77 | -2,562 | 39.6K | -6% | -$66.0K |
| 2026-05-12 16:09 | 2025-12-16 | RCUS | Ribas Antoni | Dir | G - Gift | $0.00 | -5,050 | 38.6K | -12% | $0 | |
| T | 2026-05-12 16:09 | 2026-05-11 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $25.63 | -7,763 | 84.2K | -8% | -$199.0K |
| D | 2026-01-26 | 2026-01-23 | RCUS | Markus Richard | Chief Medical Off | A - Grant | $0.00 | +24.0K | 89.6K | +37% | $0 |
| D | 2026-01-26 | 2026-01-23 | RCUS | ROSEN TERRY J | CEO, Dir | A - Grant | $0.00 | +79.0K | 2.24M | +4% | $0 |
| D | 2026-01-26 | 2026-01-23 | RCUS | Azoy Alexander | CAO | A - Grant | $0.00 | +21.1K | 39.6K | +114% | $0 |
| D | 2026-01-26 | 2026-01-23 | RCUS | Tang Carolyn C. | GC | A - Grant | $0.00 | +24.0K | 148.7K | +19% | $0 |
| D | 2026-01-26 | 2026-01-23 | RCUS | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +24.0K | 91.9K | +35% | $0 |
| D | 2026-01-26 | 2026-01-23 | RCUS | Jarrett Jennifer | COO | A - Grant | $0.00 | +31.0K | 224.0K | +16% | $0 |
| D | 2026-01-26 | 2026-01-23 | RCUS | Jaen Juan C. | Pres | A - Grant | $0.00 | +31.0K | 377.0K | +9% | $0 |
| 2026-01-09 | 2026-01-08 | RCUS | ROSEN TERRY J | CEO, Dir | G - Gift | $0.00 | -35.0K | 2.16M | -2% | $0 | |
| MI | 2026-01-07 | 2026-01-05 | RCUS | Jaen Juan C. | Pres | S - Sale | $21.41 | -31.8K | 922.2K | -3% | -$681.3K |
| T | 2026-01-02 | 2025-12-31 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $23.38 | -6,552 | 67.9K | -9% | -$153.2K |
| 2026-01-02 | 2025-12-30 | RCUS | ROSEN TERRY J | CEO, Dir | G - Gift | $0.00 | -2,400 | 2.19M | -0.1% | $0 | |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Azoy Alexander | CAO | S - Sale | $22.13 | -8,832 | 25.0K | -26% | -$195.4K |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Jarrett Jennifer | COO | S - Sale | $22.01 | -21.2K | 203.0K | -9% | -$466.8K |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Goeltz II Robert C. | CFO | S - Sale | $22.01 | -12.7K | 80.4K | -14% | -$278.7K |
| M | 2025-12-18 | 2025-12-16+ | RCUS | ROSEN TERRY J | CEO, Dir | S - Sale | $22.01 | -54.7K | 2.19M | -2% | -$1.20M |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Jaen Juan C. | Pres | S - Sale | $22.01 | -21.2K | 346.0K | -6% | -$466.8K |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Tang Carolyn C. | GC | S - Sale | $22.01 | -14.5K | 124.7K | -10% | -$318.5K |
| M | 2025-12-18 | 2025-12-16+ | RCUS | Markus Richard | Chief Medical Off | S - Sale | $22.01 | -9,546 | 70.1K | -12% | -$210.1K |
| I | 2025-12-05 | 2025-12-04 | RCUS | Jaen Juan C. | Pres | S - Sale | $24.71 | -83.0K | 954.1K | -8% | -$2.05M |
| D | 2025-12-01 | 2025-11-26 | RCUS | Azoy Alexander | CAO | S - Sale+OE | $26.00 | -1,900 | 27.4K | -6% | -$49.4K |
| D | 2025-12-01 | 2025-11-26 | RCUS | Azoy Alexander | CAO | M - OptEx | $13.33 | +1,900 | 29.3K | +7% | +$25.3K |
| 2025-11-26 | 2025-11-26 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $25.00 | -5,000 | 87.1K | -5% | -$125.0K | |
| MI | 2025-11-19 | 2025-11-17+ | RCUS | Jaen Juan C. | Pres | S - Sale | $20.26 | -50.0K | 1.04M | -5% | -$1.01M |
| D | 2025-11-12 | 2025-11-07 | RCUS | Jarrett Jennifer | COO | S - Sale+OE | $18.97 | -50.3K | 214.2K | -19% | -$954.0K |
| D | 2025-11-12 | 2025-11-07 | RCUS | Jarrett Jennifer | COO | M - OptEx | $1.23 | +50.3K | 264.5K | +23% | +$61.9K |
| I | 2025-11-03 | 2025-10-30 | RCUS | Jaen Juan C. | Pres | S - Sale | $20.32 | -4,314 | 1.09M | -0.4% | -$87.7K |
| MI | 2025-10-30 | 2025-10-28+ | RCUS | Jaen Juan C. | Pres | S - Sale | $20.76 | -96.9K | 1.09M | -8% | -$2.01M |
| 2025-10-29 | 2025-10-28 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $20.00 | -5,000 | 92.1K | -5% | -$100.0K | |
| DM | 2025-10-08 | 2025-10-06+ | RCUS | Jarrett Jennifer | COO | M - OptEx | $1.23 | +50.3K | 226.7K | +29% | +$61.9K |
| DM | 2025-10-08 | 2025-10-06+ | RCUS | Jarrett Jennifer | COO | S - Sale+OE | $14.92 | -50.3K | 214.2K | -19% | -$750.5K |
| 2025-09-30 | 2025-09-29 | RCUS | Azoy Alexander | CAO | S - Sale | $13.00 | -2,831 | 27.4K | -9% | -$36.8K | |
| 2025-09-05 | 2025-09-05 | RCUS | Azoy Alexander | CAO | S - Sale | $11.88 | -1,579 | 30.2K | -5% | -$18.8K | |
| D | 2025-06-12 | 2025-06-10 | RCUS | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +13.3K | 68.6K | +24% | $0 |
| D | 2025-06-12 | 2025-06-10 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +13.3K | 42.6K | +45% | $0 |
| D | 2025-06-12 | 2025-06-10 | RCUS | KANEKO YASUNORI | Dir | A - Grant | $0.00 | +13.3K | 33.3K | +66% | $0 |
| D | 2025-06-12 | 2025-06-10 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +13.3K | 37.3K | +55% | $0 |
| D | 2025-06-12 | 2025-06-10 | RCUS | Machado Patrick | Dir | A - Grant | $0.00 | +13.3K | 38.6K | +53% | $0 |
| D | 2025-06-12 | 2025-06-10 | RCUS | Ribas Antoni | Dir | A - Grant | $0.00 | +13.3K | 43.6K | +44% | $0 |
| D | 2025-06-12 | 2025-06-10 | RCUS | Lacey David L. | Dir | A - Grant | $0.00 | +13.3K | 71.0K | +23% | $0 |
| 2025-02-27 | 2025-02-27 | RCUS | KANEKO YASUNORI | Dir | P - Purchase | $10.06 | +20.0K | 28.4K | +238% | +$201.2K | |
| 2025-02-27 | 2025-02-27 | RCUS | ROSEN TERRY J | CEO, Dir | P - Purchase | $10.18 | +19.8K | 2.55M | +0.8% | +$201.6K | |
| 2025-02-20 | 2025-02-18 | RCUS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $11.00 | +1.36M | 31.42M | +5% | +$15.00M | |
| D | 2025-02-11 | 2025-02-10 | RCUS | Markus Richard | Chief Medical Off | A - Grant | $0.00 | +75.2K | 75.2K | New | $0 |
| D | 2025-01-27 | 2025-01-23 | RCUS | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +37.0K | 97.1K | +62% | $0 |
| D | 2025-01-27 | 2025-01-23 | RCUS | Jaen Juan C. | Pres | A - Grant | $0.00 | +50.0K | 367.2K | +16% | $0 |
| D | 2025-01-27 | 2025-01-23 | RCUS | Azoy Alexander | CAO | A - Grant | $0.00 | +17.1K | 30.2K | +131% | $0 |
| D | 2025-01-27 | 2025-01-23 | RCUS | Jarrett Jennifer | COO | A - Grant | $0.00 | +50.0K | 213.4K | +31% | $0 |
| D | 2025-01-27 | 2025-01-23 | RCUS | ROSEN TERRY J | CEO, Dir | A - Grant | $0.00 | +165.0K | 2.53M | +7% | $0 |
| D | 2025-01-27 | 2025-01-23 | RCUS | Tang Carolyn C. | GC | A - Grant | $0.00 | +37.0K | 137.6K | +37% | $0 |
| 2025-01-03 | 2024-12-31 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $15.00 | -3,594 | 60.1K | -6% | -$53.9K | |
| 2024-12-20 | 2024-12-19 | RCUS | Azoy Alexander | CAO | D - Sale to Iss | $15.17 | -3,007 | 13.1K | -19% | -$45.6K | |
| 2024-12-17 | 2024-12-15 | RCUS | Jaen Juan C. | Pres | F - Tax | $16.08 | -17.3K | 317.2K | -5% | -$278.0K | |
| 2024-12-17 | 2024-12-15 | RCUS | Goeltz II Robert C. | CFO | F - Tax | $16.08 | -10.1K | 63.7K | -14% | -$162.4K | |
| 2024-12-17 | 2024-12-15 | RCUS | Jarrett Jennifer | COO | F - Tax | $16.08 | -27.5K | 163.4K | -14% | -$442.2K | |
| 2024-12-17 | 2024-12-15 | RCUS | Azoy Alexander | CAO | F - Tax | $16.08 | -2,969 | 16.1K | -16% | -$47.7K | |
| 2024-12-17 | 2024-12-15 | RCUS | Nuyten Dimitry SA | Chief Medical Off | F - Tax | $16.08 | -7,856 | 87.5K | -8% | -$126.3K | |
| 2024-12-17 | 2024-12-15 | RCUS | ROSEN TERRY J | CEO, Dir | F - Tax | $16.08 | -37.9K | 2.37M | -2% | -$609.1K | |
| 2024-12-17 | 2024-12-15 | RCUS | Tang Carolyn C. | GC | F - Tax | $16.08 | -11.3K | 100.6K | -10% | -$182.3K | |
| 2024-12-04 | 2024-12-02 | RCUS | Azoy Alexander | CAO | S - Sale | $15.32 | -201 | 19.1K | -1% | -$3,079 | |
| 2024-09-17 | 2024-09-15 | RCUS | Nuyten Dimitry SA | Chief Medical Off | F - Tax | $17.95 | -5,385 | 94.9K | -5% | -$96.7K | |
| 2024-09-17 | 2024-09-15 | RCUS | Jarrett Jennifer | COO | F - Tax | $17.95 | -12.7K | 190.4K | -6% | -$227.4K | |
| 2024-08-15 | 2024-08-13 | RCUS | Azoy Alexander | CAO | S - Sale | $14.97 | -1,357 | 19.1K | -7% | -$20.3K | |
| 2024-06-18 | 2024-06-15 | RCUS | Tang Carolyn C. | GC | F - Tax | $16.97 | -4,182 | 111.4K | -4% | -$71.0K | |
| 2024-06-18 | 2024-06-15 | RCUS | Jaen Juan C. | Pres | F - Tax | $16.97 | -6,969 | 334.5K | -2% | -$118.3K | |
| 2024-06-18 | 2024-06-15 | RCUS | ROSEN TERRY J | CEO, Dir | F - Tax | $16.97 | -12.7K | 3.95M | -0.3% | -$215.0K | |
| 2024-06-18 | 2024-06-15 | RCUS | Jarrett Jennifer | COO | F - Tax | $16.97 | -12.7K | 203.1K | -6% | -$215.0K | |
| D | 2024-06-07 | 2024-06-06 | RCUS | PERLMAN ANDREW J | Dir | A - Grant | $0.00 | +8,400 | 29.3K | +40% | $0 |
| D | 2024-06-07 | 2024-06-06 | RCUS | KANEKO YASUNORI | Dir | A - Grant | $0.00 | +8,400 | 15.2K | +124% | $0 |
| D | 2024-06-07 | 2024-06-06 | RCUS | Ribas Antoni | Dir | A - Grant | $0.00 | +8,400 | 30.4K | +38% | $0 |
| D | 2024-06-07 | 2024-06-06 | RCUS | Machado Patrick | Dir | A - Grant | $0.00 | +8,400 | 25.3K | +50% | $0 |
| D | 2024-06-07 | 2024-06-06 | RCUS | FALBERG KATHRYN E | Dir | A - Grant | $0.00 | +8,400 | 55.3K | +18% | $0 |
| D | 2024-06-07 | 2024-06-06 | RCUS | Lambert Nicole | Dir | A - Grant | $0.00 | +8,400 | 24.0K | +54% | $0 |
| D | 2024-06-07 | 2024-06-06 | RCUS | Lacey David L. | Dir | A - Grant | $0.00 | +8,400 | 57.7K | +17% | $0 |
| 2024-03-29 | 2024-03-27 | RCUS | Jarrett Jennifer | COO | S - Sale | $17.55 | -11.6K | 215.3K | -5% | -$202.7K | |
| M | 2024-03-20 | 2024-03-18 | RCUS | Jarrett Jennifer | COO | S - Sale | $17.92 | -13.4K | 228.1K | -6% | -$240.9K |
| M | 2024-02-28 | 2024-02-26+ | RCUS | Jarrett Jennifer | COO | S - Sale | $20.09 | -58.6K | 274.3K | -18% | -$1.18M |
| MI | 2024-02-28 | 2024-02-26+ | RCUS | Jaen Juan C. | Pres | S - Sale | $20.09 | -27.0K | 1.19M | -2% | -$543.2K |
| A | 2024-02-23 | 2024-01-23 | RCUS | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +22.0K | 73.8K | +42% | $0 |
| 2024-01-31 | 2024-01-29 | RCUS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $21.00 | +15.24M | 30.06M | +103% | +$320.00M | |
| D | 2024-01-25 | 2024-01-23 | RCUS | Jarrett Jennifer | COO, Dir | A - Grant | $0.00 | +40.0K | 298.9K | +15% | $0 |
| D | 2024-01-25 | 2024-01-23 | RCUS | Nuyten Dimitry SA | Chief Medical Off | A - Grant | $0.00 | +28.0K | 99.2K | +39% | $0 |
| D | 2024-01-25 | 2024-01-23 | RCUS | Goeltz II Robert C. | CFO | A - Grant | $0.00 | +21.3K | 73.1K | +41% | $0 |
| D | 2024-01-25 | 2024-01-23 | RCUS | Jaen Juan C. | Pres, Dir | A - Grant | $0.00 | +40.0K | 341.5K | +13% | $0 |
| D | 2024-01-25 | 2024-01-23 | RCUS | Azoy Alexander | CAO | A - Grant | $0.00 | +8,850 | 19.1K | +87% | $0 |
| D | 2024-01-25 | 2024-01-23 | RCUS | ROSEN TERRY J | CEO, Dir | A - Grant | $0.00 | +100.0K | 3.97M | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations